His main research concerns Circulating tumor cell, Pathology, Internal medicine, Oncology and Immunology. His Circulating tumor cell study integrates concerns from other disciplines, such as Whole blood, Surgery, Metastatic breast cancer, Tumor progression and Epithelial cell adhesion molecule. His biological study spans a wide range of topics, including Cancer research, Antibody, Flow cytometry and Prostate cancer.
His Flow cytometry research is multidisciplinary, incorporating perspectives in Cytokeratin and Antigen. His study in Oncology is interdisciplinary in nature, drawing from both Colorectal cancer and Tumor cells. His Immunology research is multidisciplinary, incorporating elements of CD34, Haematopoiesis, Cellular differentiation and Cell biology.
The scientist’s investigation covers issues in Circulating tumor cell, Internal medicine, Oncology, Pathology and Cancer. Leon W.M.M. Terstappen combines subjects such as Cancer research, Breast cancer, Metastatic breast cancer, Liquid biopsy and Prostate cancer with his study of Circulating tumor cell. His study in the field of Overall survival also crosses realms of In patient.
Pathology is closely attributed to Flow cytometry in his work. As part of the same scientific family, Leon W.M.M. Terstappen usually focuses on Flow cytometry, concentrating on Antigen and intersecting with Antibody. His Bone marrow study also includes
Leon W.M.M. Terstappen mainly focuses on Circulating tumor cell, Cancer, Internal medicine, Oncology and Lung cancer. Leon W.M.M. Terstappen interconnects Cancer research, Metastatic breast cancer, Leukapheresis, Liquid biopsy and Cancer biomarkers in the investigation of issues within Circulating tumor cell. His Cancer research incorporates themes from Cell, Antibody and Tumor cells.
His Oncology study combines topics from a wide range of disciplines, such as Colorectal cancer, Proportional hazards model, Chemotherapy and Hazard ratio. His Lung cancer research is multidisciplinary, incorporating elements of Progression-free survival and Immunotherapy. His Breast cancer study integrates concerns from other disciplines, such as Clinical research and Concordance.
His scientific interests lie mostly in Circulating tumor cell, Prostate cancer, Oncology, Internal medicine and Cancer biomarkers. His Circulating tumor cell research includes themes of Prostate, Liquid biopsy, Molecular biology, Lung cancer and Primary tumor. His study in the fields of Patient summary under the domain of Prostate cancer overlaps with other disciplines such as Voting.
His biological study spans a wide range of topics, including Cancer, Proportional hazards model, Chemotherapy and Hazard ratio. His work on Breast cancer as part of general Cancer research is often related to Health economics and Reimbursement, thus linking different fields of science. He has included themes like Intensive care medicine, Apheresis and Somatic evolution in cancer in his Cancer biomarkers study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Massimo Cristofanilli;G. Thomas Budd;Matthew J. Ellis;Alison Stopeck.
The New England Journal of Medicine (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases.
W. Jeffrey Allard;Jeri Matera;M. Craig Miller;Madeline Repollet.
Clinical Cancer Research (2004)
Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer
Steven J. Cohen;Cornelis J.A. Punt;Nicholas Iannotti;Bruce H. Saidman.
Journal of Clinical Oncology (2008)
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
Massimo Cristofanilli;Daniel F. Hayes;G. Thomas Budd;Mathew J. Ellis.
Journal of Clinical Oncology (2005)
Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
Leon W.M.M. Terstappen;Shiang Huang;Meredith Safford;Peter M. Lansdorp.
Circulating tumor cells in patients with breast cancer dormancy
Songdong Meng;Debasish Tripathy;Eugene P. Frenkel;Sanjay Shete.
Clinical Cancer Research (2004)
Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer
G. Thomas Budd;Massimo Cristofanilli;Mathew J. Ellis;Allison Stopeck.
Clinical Cancer Research (2006)
Detection and characterization of carcinoma cells in the blood
Emilian Racila;David Euhus;Arthur J. Weiss;Chandra Rao.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard;Joost F. Swennenhuis;David Olmos;Alison H.M. Reid.
Cancer Research (2009)
HER-2 gene amplification can be acquired as breast cancer progresses.
Songdong Meng;Debasish Tripathy;Sanjay Shete;Raheela Ashfaq.
Proceedings of the National Academy of Sciences of the United States of America (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: